Related Experiment Video
Updated: Apr 25, 2026

Primary Microglia Isolation from Mixed Glial Cell Cultures of Neonatal Rat Brain Tissue
Published on: August 15, 2012
Therapeutic molecules and endogenous ligands regulate the interaction between brain cellular prion protein (PrPC) and
Laura T Haas1, Mikhail A Kostylev2, Stephen M Strittmatter3
1From the Cellular Neuroscience, Neurodegeneration and Repair Program, Department of Neurology, Yale University School of Medicine, New Haven, Connecticut 06536 and the Graduate School of Cellular and Molecular Neuroscience, University of Tübingen, D-72074 Tübingen, Germany.
Abstract:
Soluble Amyloid-β oligomers (Aβo) can trigger Alzheimer disease (AD) pathophysiology by binding to cell surface cellular prion protein (PrP(C)). PrP(C) interacts physically with metabotropic glutamate receptor 5 (mGluR5), and this interaction controls the transmission of neurotoxic signals to intracellular substrates. Because the interruption of the signal transduction from PrP(C) to mGluR5 has therapeutic potential for AD, we developed assays to explore the effect of endogenous ligands, agonists/antagonists, and antibodies on the interaction between PrP(C) and mGluR5 in cell lines and mouse brain. We show that the PrP(C) segment of amino acids 91-153 mediates the interaction with mGluR5. Agonists of mGluR5 increase the mGluR5-PrP(C) interaction, whereas mGluR5 antagonists suppress protein association. Synthetic Aβo promotes the protein interaction in mouse brain and transfected HEK-293 cell membrane preparations. The interaction of PrP(C) and mGluR5 is enhanced dramatically in the brains of familial AD transgenic model mice. In brain homogenates with Aβo, the interaction of PrP(C) and mGluR5 is reversed by mGluR5-directed antagonists or antibodies directed against the PrP(C) segment of amino acids 91-153. Silent allosteric modulators of mGluR5 do not alter Glu or basal mGluR5 activity, but they disrupt the Aβo-induced interaction of mGluR5 with PrP(C). The assays described here have the potential to identify and develop new compounds that inhibit the interaction of PrP(C) and mGluR5, which plays a pivotal role in the pathogenesis of Alzheimer disease by transmitting the signal from extracellular Aβo into the cytosol.
Insights
Soluble amyloid-beta oligomers trigger Alzheimer
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Soluble amyloid-beta oligomers (Aβo) initiate Alzheimer disease (AD) pathophysiology.
- Cellular prion protein (PrP(C)) binds Aβo and interacts with metabotropic glutamate receptor 5 (mGluR5).
- This PrP(C)-mGluR5 interaction transmits neurotoxic signals, presenting a therapeutic target for AD.
Purpose of the Study:
- To develop assays for studying the PrP(C)-mGluR5 interaction.
- To investigate the effects of ligands, agonists, antagonists, and antibodies on this interaction.
- To identify potential therapeutic strategies for inhibiting PrP(C)-mGluR5 signaling in AD.
Main Methods:
- Utilized cell lines and mouse brain models.
- Developed assays to measure PrP(C)-mGluR5 interaction.
- Tested endogenous ligands, agonists, antagonists, antibodies, and silent allosteric modulators.
Main Results:
- The PrP(C) segment (amino acids 91-153) mediates mGluR5 interaction.
- mGluR5 agonists enhance, while antagonists suppress, the interaction.
- Aβo promotes PrP(C)-mGluR5 interaction, significantly increased in AD models; this can be reversed by antagonists or anti-PrP(C) antibodies.
- Silent allosteric mGluR5 modulators disrupt Aβo-induced PrP(C)-mGluR5 interaction without affecting basal activity.
Conclusions:
- The PrP(C)-mGluR5 interaction is a key pathway for Aβo-induced neurotoxicity in Alzheimer disease.
- mGluR5 antagonists and specific antibodies targeting PrP(C) can reverse this interaction.
- Silent allosteric modulators offer a novel therapeutic approach by disrupting the pathogenic signaling cascade.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
GPCR Desensitization
Antiepileptic Drugs: Glutamate Antagonists
Neurochemical Transmission: Sites of Drug Action

